Influence of COX-2 and local cytokine expressions in gastric ulcer mucosa by H. pylori and NSAID

Hepato-Gastroenterology

Volumn 53, Issue 71, 2006, Pages 797-803

  Wu, Chun Ying ^a,b,c   Wu, Ming Shing ^d   Chen, Yi Ju ^e   Chen, Chien Jen ^f   Lin, Jaw Town ^a,d   Chen, Gran Hum ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

COX 2; Gastric ulcer; H pylori; IL 8; NSAID; TNF

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; INTERLEUKIN 4; INTERLEUKIN 8; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG USE; FEMALE; GASTROSCOPY; HELICOBACTER PYLORI; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH BIOPSY; STOMACH MUCOSA; STOMACH ULCER;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-4; INTERLEUKIN-8; INTESTINAL MUCOSA; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROSPECTIVE STUDIES; PYLORIC ANTRUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH ULCER; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 33750596551     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hawkey CJ: Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 2000; 119(21:521-535. (PMID: 10930388)
2. Huang JQ, Sridhar S, Hunt RH: Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002; 359(9300):14-22. (PMID: 11809181)
3. Chan FK: Helicobacter pylori, NSAIDs and gastrointestinal haemorrhage. Eur J Gastroenterol Hepatol 2002; 14(1):1-3. (PMID: 11782567)
4. Bianchi PG, Parente F, Imbesi V, Montrone F, Causo I: Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy. Gut 1996; 39(1):22-26. (PMID: 8881802)
5. Hunt RH, Sumanac K, Huang JQ: Review article: should we kill or should we save Helicobacter pylori? Aliment Pharmacol Ther 2001; 15(Suppl 1):51-59. (PMID: 11488662)
6. Peterson WL: Helicobacter pylori. In: Feldman M, (Ed.). Gastrointestinal and Liver Diseases: Pathophysiology/Diagnosis Management. Philadelphia: W.B. Saunders, 1998; pp. 604-619.
7. Hawkey CJ, Tulassay Z, Szczepanski L, van Rensburg CJ, Filipowicz-Sosnowska A, Lanas A, Wason CM, Peacock RA, Gillon KR: Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention. Lancet 1998; 352(9133):1016-1021. (PMID: 9759744)
8. Chan FK, Sung JJ, Chung SC, To KF, Yung MY, Leung VK, Lee YT, Chan CS, Li EK, Woo J: Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997; 350(9083):975-979. (PMID: 9329511)
9. Fan XG, Chua A, Fan XJ, Keeling PW: Increased gastric production of interleukin-8 and tumour necrosis factor in patients with Helicobacter pylori infection. J Clin Pathol 1995; 48(2):133-136. (PMID: 7745112)
10. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN: Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994: 29(5):425-429. (PMID: 8036458)
11. Mattapallil JJ, Dandekar S, Canfield DR, Solnick JV: A predominant Th1 type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques. Gastroenterology 2000; 118(2):307-315. (PMID: 10648459)
12. Smythies LE, Waites KB, Lindsey JR, Harris PR, Ghiara P, Smith PD: Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol 2000; 165(2):1022-1029. (PMID: 10878379)
13. Lindhohn C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM: Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998; 66(12):S964-5971. (PMID: 9826379)
14. Holck S, Norgaard A, Bennedsen M, Permin H, Norn S, Andersen LP: Gastric mucosal cytokine responses in Helicobacter pylori-infected patients with gastritis and peptic ulcers. Association with inflammatory parameters and bacteria load. FEMS Immunol Med Microbiol 2003; 36(3):175-180. (PMID: 12738388)
15. Ernst PB, Crowe SE, Reyes VE: How does Helicobacter pylori cause mucosal damage? The inflammatory response. Gastroenterologe 1997; 113(6 Suppl):S35-S42. (PMID: 9394758)
16. Kim H, Lim JW, Kim KH: Helicobacter pylori-induced expression of interleukin-8 and cyclooxygenase-2 in AGS gastric epithelial cells: mediation by nuclear factor-kappaB. Scand J Gastroenterol 2001; 36(7):706-716. (PMID: 11444469)
17. McCarthy CJ, Crofford LJ, Greenson J, Scheiman JM: Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection. Am J Gastroenterol 1999; 94(5):1218-23. (PMID: 10235197)
18. To KF, Chan FK, Cheng AS, Lee TL, NgYP, Sung JJ: Up-regulation of cyclooxygenase-1 and -2 in human gastric ulcer. Aliment Pharmacol Ther 2001. 15(1):25-34. (PMID: 11136275)
19. Tatsuguchi A, Sakamoto C, Wada K, Akamatsu T, Tsukui T, Miyake K, Futagami S, Kishida T, Fukuda Y, Yamanaka N, Kobayashi M: Localisation of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori related gastritis and gastric ulcer tissues in humans. Gut 2000; 46(6):782-789. (PMID: 10807888)
20. Beck PL, Xavier R, Lu N, Nanda NN, Dinauer M, Podolsky DK, Seed B: Mechanisms of NSAID-induced gastrointestinal injury defined using mutant mice. Gastroenterology 2000; 119(3):699-705. (PMID: 10982764)
21. Paccani SR, Boncristiano M, Ulivieri C, D'Elios MM, Del Prete G, Baldari CT: Nonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAPK induction. J Biol Chem 2002; 277(2):1509-1513. (PMID: 11700329)
22. Bontems P, Robert F, Van Gossum A, Cadranel S, Mascart F: Helicobacter pylori modulation of gastric and duodenal mucosal T cell cytokine secretions in children compared with adults. Helicobacter 2003; 8(3):216-226. (PMID: 12752734)
23. Holck S, Norgaard A, Bennedsen M, Permin H, Norn S, Anderson LP: Gastric mucosal cytokine responses in Helicobacter pylori-infected patients with gastritis and pepticulcers. Association with inflammatory parameters and bacteria load. FEMS Immunol Med Microbiol 2003; 36(3):175-180. (PMID: 12738388)
24. Shiotani A, Yamaoka Y, El Zimaity HM, Saeed MA. Qureshi WA, Graham DY: NSAID gastric ulceration: predictive value of gastric pH, mucosal density of polymorphonuclear leukocytes, or levels of IL-8 or nitrite. Dig Dis Sci 2002; 47(1):38-43. (PMID: 11852880)
25. Jackson LM, Wu KC, Mahida YR, Jenkins D, Hawkey CJ: Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa. Gut 2000; 47(6):762-770 (PMID: 11076873)
26. Guiraldes E, Duarte I, Pena A, Godoy A, Espinosa MN, Bravo R, Larrain F, Schultz M, Harris P: Proinflammatory cytokine expression in gastric tissue from children with Helicobacter pylori-associated gastritis. J Pediatr Gastroenterol Nutr 2001; 33(2):127-132. (PMID: 1156851)
27. Felley CP, Pignatelli B, Van Melle GD, Crabtree JE, Stolte M, Diezi J, Corthesy-Theulaz I, Michetti P, Bancel B, Patricot LM, Ohshima H, Felley-Bosco E: Oxidative stress in gastric mucosa of asymptomatic humans infected with Helicobacter pylori: effect of bacterial eradication. Helicobacter 2002; 7(6):342-348. (PMID: 12485120)
28. Chan FK, Sung JJ, Suen R, Lee YT, Wu JC, Leung WK, Chan HL, Lai AC, Lau JY, Ng EK, Chung SC: Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study. Aliment Pharmacol Ther 1998; 12(12):1201-1205. (PMID: 9882027)
29. Wallace JL: Non-steroidal anti-inflammatory drug gastropathy and cytoprotection: pathogenesis and mechanisms re-examined. Scand J Gastroenterol Suppl 1992; 192:3-8. (PMID: 1439567)
30. Taha AS, Dahill S, Morran C, Hudson N, Hawkey CJ, Lee FD, Sturrock RD, Russell RI: Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers. Gastroenterology 1999; 116(2):254-258. (PMID: 9922304)
31. Halter F, Tarnawski AS, Schmassmann A, Peskar BM: Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives. Gut 2001; 49(3):443-453. (PMID: 11511570)
32. Kishimoto Y, Wada K, Nakamoto K, Kawasaki H, Hasegawa J: Levels of cyclooxygenase-1 and -2 mRNA expression at various stages of acute gastric injury induced by ischemia-reperfusion in rats. Arch Biochem Biophys 1998; 352(1):153-157. (PMID: 9521828)
33. Shigeta J, Takahashi S, Okabe S: Role of cyclooxygenase-2 in the healing of gastric ulcers in rats. J Pharmacol Exp Ther 1998; 286(3):1383-1390. (PMID: 9732401)
34. Guo JS, Cho CH, Lam Liu ES, Choy HT, Wang JY, Leung Koo MW: Antiangiogenic effect of a highly selective cyclooxygenase-2 inhibitor on gastric ulcer healing in rats. Toxicol Appl Pharmacol 2002; 183(1):41-45. (PMID: 12217640)